IP IPX IperionX Limited Loading... : Investor Sentiment and Bull/Bear Views

Author's alert flags 'IPX ... STOPPED,' indicating the portfolio's IPX position hit its stop level and was closed — a breakdown of the prior long setup with no new thesis or revised entry offered to subscribers. Risk: No price or size is disclosed, so the stop level is unknown and may have been a volatility-driven technical exit rather than a fundamental deterioration.

The push to reduce reliance on Chinese minerals for defense creates growth opportunities for domestic rare earth and metal producers.

IperionX offers a unique domestic solution to the U.S. titanium supply chain bottleneck by using patented HAMR and HSPT technologies that bypass the traditional, foreign-dependent Kroll process. With significant U.S. government funding and active commercial partnerships in defense and automotive, the company is positioned to scale production, though it remains pre-revenue and faces execution risks. The primary risk is the unproven commercial scalability of its technology and potential shifts in defense program priorities like the XM30.

IperionX (IPX) is producing titanium in Virginia using a University of Utah process that makes titanium powders at roughly 80% lower cost; it has received $115 million from the Department of Defense to scale titanium capability, and 25% of an F-35 is titanium. If commercialization succeeds, it could be a key Western materials company.

IperionX/IPX is producing titanium in Virginia using a University of Utah process that can make titanium powders at about 80% less cost. It has received roughly $115 million from the Department of Defense to scale titanium capabilities, and Craig says it has virtually reached commercialization. Titanium is critical to F-35s and defense supply chains.